Inova Diagnostics has unveiled a rapid-response chemiluminescent analyzer with Quanta Flash reagents for autoimmune disease diagnostic testing.
The Bio-Flash analyzer, which uses chemiluminescent technology, is designed for use in clinical reference and hospital laboratories for providing full automation of a broad menu of highly accurate Quanta Flash immunoassays for autoimmunity testing.
Bio-Flash and the Quanta Flash reagents, which are classified as moderately complex under the Clinical Laboratories Improvements Act (CLIA), generate first result in as little as 30 minutes, with additional results in one per minute thereafter, claims the company.
The analyzer also offers other benefits including an increased analytical measuring range, onboard dilution and stored calibration.
Alberta Research and Innovation Authority chairman and University of Calgary professor of medicine and Arthritis Society Research chair Dr Marvin Fritzler said Bio-Flash has dramatically enhanced the workflow and decreased turnaround times for autoantibody testing at his laboratory.
"The user-friendly interface allows rapid adoption by laboratory staff members," Fritzler added.
"We are looking forward to an expanding catalogue of immunoassays developed by INOVA."